Uvantis Therapeutics, Inc.

New Filing
CIK: 0002156954·Biotechnology·DELAWARE·Filed: Sep 23, 2026
Total Offering

$5,000,000

Amount Sold

$100,000

Investors

1

First Sale

Sep 10, 2026

Offering Details

Type
Debt, Option to Acquire
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2025
Non-Accredited Investors
No

Related Persons

NameRole
William Sheahan
Jonathan Young
Edward Woo
Paul Giannasca
Jeffrey Collins

Company

Uvantis Therapeutics, Inc.

10980 GRANTCHESTER WAY

COLUMBIA, MD, 21044

6174176695

SEC Filing

0002156954-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free